The expansion of liquefied natural gas demand is driving market growth.
The cryogenic valve market is projected to exhibit a compound annual growth rate (CAGR) of 6.4% during the forecast period from 2024 to 2034. The market size in 2023 is estimated to be $4 billion, and it is expected to reach $7.9 billion by 2034. Cryogenic valves are specially designed components used to regulate the flow of fluids at extremely low temperatures, typically below -150°C (-238°F). These valves are critical for industries that handle cryogenic liquids and gases, such as liquefied natural gas (LNG) processing, aerospace, and medical applications. Cryogenic valves are made from materials like stainless steel, bronze, or exotic alloys such as Inconel. They are designed to withstand thermal stresses at sub-zero temperatures and maintain sealing integrity. By extending bonnet and stem extensions, they shield critical components from extreme cold, preventing issues such as freezing and valve lock-up. This research report investigates the cryogenic valve market, providing trends and forecasts from 2024 to 2034, categorized by type, cryogenic type, application, end-user, and region.
Inquire About This Product
basic information
Publisher: Fatpos Global Publication Month: August 2024 Report Language: English *For more details, please visit our website or refer to the sample materials.
Price range
P4
Delivery Time
P2
Applications/Examples of results
In the research report, we provide data that serves as the basis for corporate strategies and decision-making. You can check the delivery image from the sample. We can also introduce reports from our collection that are close to your preferences. Please feel free to contact us for any inquiries or consultations.
Company information
Data Resource Co., Ltd. provides valuable information and analytical data for business strategy planning, including the latest market information on telecommunications, computers, electronics, semiconductors, energy, automotive-related sectors, as well as healthcare and pharmaceuticals, competitive strategies of other companies, development of new technologies and services, regulations, and intellectual property.